Abiopharma

News list

Director Lo Steven 🟡 adjusted position in 97.2K shares of Vaxart, Inc. (VXRT) at $0.37 Transaction Date: Dec 04, 2025 | Filing ID: 037206

Full text

News bot Dec. 9, 2025, 2:45 a.m.
🔍 Lo Steven (Director)

Company: Vaxart, Inc. (VXRT)

Report Date: 2025-12-04
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 151,351
- Total shares sold: 54,153
- Total shares held: 100,000
Detailed Transactions and Holdings:
- Acquired 151,351 shares of Common Stock (Direct)
  Date: 2025-12-04 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,841,712.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Sold 54,153 shares of Common Stock at $0.37 per share (Direct)
  Date: 2025-12-04 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,787,559.00 | transaction_form_type: 4 | Footnotes: F3
- Holds 0 shares of Common Stock (Direct)
  Date: 2025-12-04 | Code: H | nature_of_ownership: By the Lo Family Trust | shares_owned_after: 100,000.00
Footnotes:
- F1: Grant of shares upon vesting of restricted stock units, which fully vested on December 4, 2025.
- F2: This amount includes 57,723 shares acquired under the Vaxart, Inc. 2022 Employee Stock Purchase Plan.
- F3: Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of December 4, 2025.